• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Akamai Technologies Issues Weak Outlook, Joins Applied Optoelectronics, JFrog And Other Big Stocks Moving Lower In Friday's Pre-Market Session

    5/10/24 5:45:15 AM ET
    $AAOI
    $AKAM
    $DNA
    $FROG
    Semiconductors
    Technology
    Real Estate
    Real Estate
    Get the next $AAOI alert in real time by email

    U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Friday.

    Shares of Akamai Technologies, Inc. (NASDAQ:AKAM) fell sharply in today's pre-market trading after the company issued weak guidance.

    The company said it sees FY24 adjusted EPS of $6.20 to $6.40 compared to market estimates of $6.73. It expects revenue of $3.95 billion to $4.02 billion, versus expectations of $4.08 billion, according to data from Benzinga Pro.

    Akamai Technologies shares dipped 10.4% to $91.73 in pre-market trading.

    Here are some big stocks recording losses in today's pre-market trading session.

    • MacroGenics, Inc. (NASDAQ:MGNX) shares tumbled 64.5% to $5.20 in pre-market trading after the company reported worse-than-expected first-quarter financial results.
    • Progyny, Inc. (NASDAQ:PGNY) shares declined 36% to $20.80 pre-market trading after the company reported worse-than-expected first-quarter sales results and issued FY24 sales guidance below estimates.
    • MicroVision, Inc. (NASDAQ:MVIS) shares declined 27.2% to $1.18 in pre-market trading after the company reported worse-than-expected first-quarter GAAP EPS results.
    • Applied Optoelectronics, Inc. (NASDAQ:AAOI) shares declined 16.4% to $8.79 in pre-market trading after the company issued weak second-quarter guidance.
    • JFrog Ltd. (NASDAQ:FROG) shares dipped 13.4% to $35.10 in pre-market trading after the company reported first quarter financial results.
    • Navitas Semiconductor Corporation (NASDAQ:NVTS) shares fell 10.4% to $4.20 in pre-market trading after the company reported worse-than-expected first-quarter adjusted EPS results.
    • Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) shares fell 10.4% to $0.8243 in pre-market trading after the company reported worse-than-expected first-quarter sales results.
    • indie Semiconductor, Inc. (NASDAQ:INDI) shares dipped 9.2% to $5.26 in pre-market trading following weak quarterly results.
    • Yelp Inc. (NYSE:YELP) shares declined 7.1% to $36.80 pre-market trading after the company reported a first-quarter revenue miss.
    • Runway Growth Finance Corp. (NASDAQ:RWAY) shares fell 6.1% to $11.37 in pre-market trading as the company priced its secondary offering of 3.75 million common stock by selling stockholder at $11.50 per share.

    Now Read This: Enbridge, Funko And 3 Stocks To Watch Heading Into Friday

    Don't forget to check out our premarket coverage here

    Get the next $AAOI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAOI
    $AKAM
    $DNA
    $FROG

    CompanyDatePrice TargetRatingAnalyst
    Progyny Inc.
    $PGNY
    1/20/2026$30.00Mkt Perform → Mkt Outperform
    Citizens JMP
    Akamai Technologies Inc.
    $AKAM
    1/16/2026$88.00 → $103.00Neutral
    Citigroup
    Akamai Technologies Inc.
    $AKAM
    1/12/2026$115.00Underweight → Overweight
    Morgan Stanley
    Progyny Inc.
    $PGNY
    1/8/2026$34.00Hold → Buy
    Truist
    JFrog Ltd.
    $FROG
    12/17/2025$83.00Buy
    BTIG Research
    Akamai Technologies Inc.
    $AKAM
    12/15/2025$115.00Underweight → Overweight
    KeyBanc Capital Markets
    Progyny Inc.
    $PGNY
    12/9/2025$29.00Overweight
    Barclays
    JFrog Ltd.
    $FROG
    11/24/2025$65.00Buy → Neutral
    UBS
    More analyst ratings

    $AAOI
    $AKAM
    $DNA
    $FROG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products

    Collaboration aims to develop a commercialization-ready microorganism to manufacture next-generation peptide crop solutions at grower-friendly costsBOSTON, Feb. 18, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE:DNA, ", Ginkgo", )) and Invaio Sciences, an agricultural biotechnology company leading in nature-positive crop protection solutions, today announced a collaboration to develop strains that can efficiently manufacture peptide-based crop protection inputs. Growers are seeking inputs that protect agricultural crops from pests that are increasingly resistant to conventional chem

    2/18/26 8:00:00 AM ET
    $DNA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Applied Optoelectronics Announces Equity Grants To Employees Under Inducement Plan

    SUGAR LAND, Texas, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Applied Optoelectronics, Inc. (NASDAQ: AAOI), a leading provider of advanced optical and HFC networking products that power the internet, today announced that the Compensation Committee of its Board of Directors granted inducement awards for 3,583 shares of common stock to 6 new employees, with a grant date of February 13, 2026, pursuant to the Applied Optoelectronics, Inc. 2023 Equity Inducement Plan (the "Inducement Plan"). The Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Applied Optoelectronics, or following a bona fide period of non-employment, as an inducemen

    2/18/26 7:00:00 AM ET
    $AAOI
    Semiconductors
    Technology

    Applied Optoelectronics to Present at the Raymond James & Associates' 47th Annual Institutional Investors Conference

    SUGAR LAND, Texas, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Applied Optoelectronics, Inc. (NASDAQ:AAOI) ("AOI"), a leading provider of advanced optical and HFC networking products that power the internet, today announced the Company will present via a fireside chat at the following investor conference: Event: Raymond James & Associates' 47th Annual Institutional Investors ConferenceDate: Tuesday, March 3rd, 2026Time: 9:15 a.m. Eastern time / 8:15 a.m. Central timePresenter: Stefan Murry, Chief Financial Officer and Chief Strategy Officer A recording of the presentation will be available on the investor relations section of the company's website at investors.ao-inc.com. About Applied Optoelectr

    2/17/26 4:15:00 PM ET
    $AAOI
    Semiconductors
    Technology

    $AAOI
    $AKAM
    $DNA
    $FROG
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHIEF EXECUTIVE OFFICER Anevski Peter bought $1,930,896 worth of shares (79,500 units at $24.29), increasing direct ownership by 13% to 680,251 units (SEC Form 4)

    4 - Progyny, Inc. (0001551306) (Issuer)

    11/17/25 8:22:02 AM ET
    $PGNY
    Misc Health and Biotechnology Services
    Health Care

    Director Heiden William K bought $150,515 worth of shares (100,000 units at $1.51), increasing direct ownership by 909% to 111,000 units (SEC Form 4)

    4 - MACROGENICS INC (0001125345) (Issuer)

    8/21/25 4:19:48 PM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President and CEO Lin Chih-Hsiang (Thompson) bought $174,057 worth of shares (8,075 units at $21.56), increasing direct ownership by 0.14% to 1,663,490 units (SEC Form 4)

    4 - APPLIED OPTOELECTRONICS, INC. (0001158114) (Issuer)

    8/15/25 4:19:44 PM ET
    $AAOI
    Semiconductors
    Technology

    $AAOI
    $AKAM
    $DNA
    $FROG
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by MacroGenics Inc.

    SCHEDULE 13G/A - MACROGENICS INC (0001125345) (Subject)

    2/17/26 9:47:25 PM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Akamai Technologies Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - AKAMAI TECHNOLOGIES INC (0001086222) (Filer)

    2/17/26 4:17:33 PM ET
    $AKAM
    Real Estate

    SEC Form S-8 filed by JFrog Ltd.

    S-8 - JFrog Ltd (0001800667) (Filer)

    2/13/26 4:21:05 PM ET
    $FROG
    Computer Software: Prepackaged Software
    Technology

    $AAOI
    $AKAM
    $DNA
    $FROG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Sr VP, Research & CSO Bonvini Ezio converted options into 16,665 shares and covered exercise/tax liability with 6,433 shares, increasing direct ownership by 8% to 145,799 units (SEC Form 4)

    4 - MACROGENICS INC (0001125345) (Issuer)

    2/17/26 6:27:13 PM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    VP, Controller & Treasurer Smith Beth Ann converted options into 1,095 shares and covered exercise/tax liability with 423 shares, increasing direct ownership by 6% to 12,781 units (SEC Form 4)

    4 - MACROGENICS INC (0001125345) (Issuer)

    2/17/26 6:26:26 PM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SVP and CFO Karrels James converted options into 14,999 shares and covered exercise/tax liability with 5,790 shares (SEC Form 4)

    4 - MACROGENICS INC (0001125345) (Issuer)

    2/17/26 6:25:50 PM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAOI
    $AKAM
    $DNA
    $FROG
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for MARGENZA issued to MACROGENICS INC

    Submission status for MACROGENICS INC's drug MARGENZA (SUPPL-5) with active ingredient MARGETUXIMAB-CMKB has changed to 'Approval' on 05/25/2023. Application Category: BLA, Application Number: 761150, Application Classification:

    5/29/23 4:45:45 AM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for MARGENZA

    Submission status for MACROGENICS INC's drug MARGENZA (ORIG-1) with active ingredient MARGETUXIMAB-CMKB has changed to 'Approval' on 12/16/2020. Application Category: BLA, Application Number: 761150, Application Classification:

    12/20/20 4:31:01 PM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAOI
    $AKAM
    $DNA
    $FROG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Progyny upgraded by Citizens JMP with a new price target

    Citizens JMP upgraded Progyny from Mkt Perform to Mkt Outperform and set a new price target of $30.00

    1/20/26 8:45:21 AM ET
    $PGNY
    Misc Health and Biotechnology Services
    Health Care

    Citigroup reiterated coverage on Akamai Tech with a new price target

    Citigroup reiterated coverage of Akamai Tech with a rating of Neutral and set a new price target of $103.00 from $88.00 previously

    1/16/26 8:54:48 AM ET
    $AKAM
    Real Estate

    Akamai Tech upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Akamai Tech from Underweight to Overweight and set a new price target of $115.00

    1/12/26 7:36:51 AM ET
    $AKAM
    Real Estate

    $AAOI
    $AKAM
    $DNA
    $FROG
    Financials

    Live finance-specific insights

    View All

    Yelp Delivers Record Net Revenue in 2025 Accelerating Investment in AI Transformation

    2025 Net Revenue reached a record of $1.46 billion 2025 Net Income up 10% to $146 million 2025 Adjusted EBITDA increased 3% to $369 million1 Expects 2026 Net Revenue in the range of $1.455 billion to $1.475 billion and Adjusted EBITDA2 in the range of $310 million to $330 million Announces agreement with OpenAI Yelp Inc. (NYSE:YELP), the company that connects people with great local businesses, today posted its financial results for the fourth quarter and full year ended Dec. 31, 2025 in the Shareholder Letter available on its Investor Relations website at yelp-ir.com. "Yelp delivered record net revenue and strong profitability in 2025, driven by growth in Services and product i

    2/12/26 4:05:00 PM ET
    $YELP
    Other Consumer Services
    Consumer Discretionary

    JFrog Announces Fourth Quarter and Fiscal 2025 Results

    Total fiscal 2025 Revenues of $531.8 million; up 24% Year-over-Year Fiscal 2025 Cloud Revenues of $243.3 million; up 45% Year-over-Year Customers with ARR greater than $1 million equaled 74, up 42% Year-over-Year Fiscal 2025 JFrog Security Core equaled 7% of Revenue, 10% of ARR and 16% of RPO Ending RPO totaled $566 million, a 40% increase year over year JFrog Ltd. ("JFrog") (NASDAQ:FROG), the Liquid Software company and creators of the JFrog Software Supply Chain Platform, today announced financial results for its fourth quarter and fiscal year 2025 ended December 31, 2025. "Developers and AI coding agents are now building and releasing software together at unprecedented

    2/12/26 4:05:00 PM ET
    $FROG
    Computer Software: Prepackaged Software
    Technology

    Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2025 Results Report

    NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (NASDAQ:PGNY), a global leader in women's health and family building solutions, will report its financial results for the quarterly period and full year ended December 31, 2025, after the close of the market on Thursday, February 26, 2026. The company will host a conference call at 4:45 p.m. Eastern Time (1:45 p.m. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using t

    2/12/26 2:46:53 PM ET
    $PGNY
    Misc Health and Biotechnology Services
    Health Care

    $AAOI
    $AKAM
    $DNA
    $FROG
    Leadership Updates

    Live Leadership Updates

    View All

    JFrog Appoints Genefa Murphy as Chief Marketing Officer to Accelerate Its Next Growth Phase

    Company Extends Executive Leadership to Lead the AI-Driven Software Supply Chain Evolution JFrog Ltd. (NASDAQ:FROG), the Liquid Software company, today announced the appointment of Genefa Murphy as Chief Marketing Officer, effective immediately. Murphy brings an expansive resume to JFrog, as a seasoned CMO and go-to-market (GTM) leader with established success in driving global enterprise software growth and strategic business expansion. Coming from software development product management roots and public company GTM leadership, Ms. Murphy also holds a PhD in User Acceptance of New Technology, from the University of Wales and is a veteran of multiple boards of directors in technology and

    1/5/26 8:00:00 AM ET
    $FIVN
    $FROG
    $HPE
    EDP Services
    Technology
    Computer Software: Prepackaged Software
    Retail: Computer Software & Peripheral Equipment

    Runway Growth Capital Welcomes Ryan McCarthy as Managing Director

    McCarthy will strengthen Runway's origination efforts within the technology market. MENLO PARK, Calif., Dec. 10, 2025 /PRNewswire/ -- Runway Growth Capital LLC ("Runway"), a leading provider of growth loans to venture and non-venture–backed companies, today announced that Ryan McCarthy has joined the firm as a Managing Director. McCarthy brings nearly two decades of experience across venture debt, debt advisory, and investment banking, spanning the technology and life sciences markets. In his role at Runway, he will focus on sourcing, evaluating, and structuring new investment

    12/10/25 8:30:00 AM ET
    $RWAY
    Finance: Consumer Services
    Finance

    Einride, a Leader in Electric and Autonomous Freight, Appoints Anubhav Verma as Chief Financial Officer Ahead of Planned Public Listing

    STOCKHOLM, Nov. 24, 2025 /PRNewswire/ -- Einride AB, a technology company driving the transition to electric and autonomous freight operations for some of the world's largest shippers ("Einride" or the "Company"), today announced the appointment of Anubhav Verma as Chief Financial Officer in preparation for the Company's planned public listing on the New York Stock Exchange via its proposed business combination with Legato Merger Corp. III (NYSEAMERICAN: LEGT), a special purpose acquisition company ("Legato"). Verma, whose appointment will become effective in January 2026, brings over 16 years of global experience in capital markets, mergers and acquisitions, and strategic finance. Most rec

    11/24/25 6:55:00 AM ET
    $MVIS
    Industrial Machinery/Components
    Technology

    $AAOI
    $AKAM
    $DNA
    $FROG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Progyny Inc.

    SC 13G/A - Progyny, Inc. (0001551306) (Subject)

    12/6/24 10:11:35 AM ET
    $PGNY
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by MacroGenics Inc.

    SC 13G - MACROGENICS INC (0001125345) (Subject)

    11/20/24 10:44:27 AM ET
    $MGNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Runway Growth Finance Corp.

    SC 13D/A - Runway Growth Finance Corp. (0001653384) (Subject)

    11/14/24 7:44:26 PM ET
    $RWAY
    Finance: Consumer Services
    Finance